Clinical Trial Update: A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the drug interaction between BAY2927088 and Midazolam, assessing whether BAY2927088 alters Midazolam exposure when co-administered in h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BAY2927088
• Midazolam (Midazolam)

Snippet

Sponsor: Bayer | Conditions: Advanced Non-small Cell Lung Cancer, EGFR Mutation | Phase 1 | Status: COMPLETED